Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis

NCT04598269 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: ATI-1777
DRUG: Vehicle

Sponsor

Aclaris Therapeutics, Inc.